THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA warns on anemia-drug dosing

Alert raises concerns on Medicare-fee rules for dialysis industry

By Christopher Rowland
Globe Staff / November 18, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The Food and Drug Administration yesterday warned doctors not to excessively boost patients' red blood cell counts with anti anemia drugs, following publication of a clinical trial this week that found exceeding the FDA's dosing recommendations increased the chance of fatal heart attacks and strokes. (Full article: 616 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass